Target intelligence / Profile preview

Potassium channel subfamily K member 13 (THIK-1) (THIK-1)

Target
THIK-1
Molecular classification
Ion channel, Two-pore domain potassium channel, K2P channel
01

Overview

Potassium channel subfamily K member 13 (KCNK13), commonly known as THIK-1, is a two-pore domain potassium (K2P) channel that plays a pivotal role in the central nervous system (UniProt Q9HB14). It is the most abundant potassium channel expressed in microglia, where it is the primary regulator of the resting membrane potential (Madry et al., 2018). THIK-1 activity is essential for microglial surveillance, allowing these cells to constantly monitor the brain environment for damage or pathogens. Furthermore, this channel facilitates the release of interleukin-1 beta (IL-1β) through the NLRP3 inflammasome pathway, linking ion flux to inflammatory signaling (Izquierdo et al., 2021). Consequently, THIK-1 has emerged as a significant therapeutic target for neuroinflammatory and neurodegenerative conditions, such as Alzheimer's disease and stroke, where microglial dysfunction contributes to pathology. Pharmacological modulation, typically through inhibition by compounds like tetrapentylammonium or certain anesthetics, can suppress excessive microglial activation and pro-inflammatory signaling (Rajan et al., 2001). Targeting THIK-1 offers a unique opportunity to modulate the brain's innate immune response without directly affecting neuronal excitability, given its high enrichment in microglia.

Other names
KCNK13Tandem pore domain halothane-inhibited potassium channel 1K2P13.1THIK1
02

Mechanism of action

THIK-1 functions as a background potassium leak channel that maintains the negative resting membrane potential of microglia; its inhibition leads to membrane depolarization, which impairs microglial motility and surveillance while also preventing the assembly of the NLRP3 inflammasome and subsequent IL-1β secretion (Madry et al., 2018; Izquierdo et al., 2021).

03

Biological functions

Maintenance of resting membrane potentialMicroglial surveillanceCytokine secretionPotassium homeostasisNLRP3 inflammasome regulation
04

Disease associations

NeuroinflammationAlzheimer's diseaseParkinson's diseaseStrokeChronic pain
05

Safety considerations

Potential off-target effects on other two-pore domain potassium channels (K2P) such as TASK or TREKRisk of impairing beneficial homeostatic microglial functionsLack of highly selective clinical-grade inhibitors
06

Interacting drugs

Tetrapentylammonium

4 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1β) levelsTSPO-PET imaging

Beyond the preview

Go deeper on Potassium channel subfamily K member 13 (THIK-1) (THIK-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 13 (THIK-1) (THIK-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call